Literature DB >> 11353826

Horizontal transfer of oncogenes by uptake of apoptotic bodies.

A Bergsmedh1, A Szeles, M Henriksson, A Bratt, M J Folkman, A L Spetz, L Holmgren.   

Abstract

Tumor formation involves the accumulation of a series of genetic alterations that are required for malignant growth. In most malignancies, genetic changes can be observed at the chromosomal level as losses or gains of whole or large portions of chromosomes. Here we provide evidence that tumor DNA may be horizontally transferred by the uptake of apoptotic bodies. Phagocytosis of apoptotic bodies derived from H-ras(V12)- and human c-myc-transfected rat fibroblasts resulted in loss of contact inhibition in vitro and a tumorigenic phenotype in vivo. Fluorescence in situ hybridization analysis revealed the presence of rat chromosomes or of rat and mouse fusion chromosomes in the nuclei of the recipient murine cells. The transferred DNA was propagated, provided that the transferred DNA conferred a selective advantage to the cell and that the phagocytotic host cell was p53-negative. These results suggest that lateral transfer of DNA between eukaryotic cells may result in aneuploidy and the accumulation of genetic changes that are necessary for tumor formation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353826      PMCID: PMC33481          DOI: 10.1073/pnas.101129998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

2.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 3.  Molecular themes in oncogenesis.

Authors:  J M Bishop
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

4.  Functional gene transfer of HIV DNA by an HIV receptor-independent mechanism.

Authors:  A L Spetz; B K Patterson; K Lore; J Andersson; L Holmgren
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats.

Authors:  W Bursch; S Paffe; B Putz; G Barthel; R Schulte-Hermann
Journal:  Carcinogenesis       Date:  1990-05       Impact factor: 4.944

8.  Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia.

Authors:  W Bursch; H S Taper; B Lauer; R Schulte-Hermann
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

9.  Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Authors:  D Pinkel; T Straume; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  160 in total

Review 1.  Horizontal transfer of microRNAs: molecular mechanisms and clinical applications.

Authors:  Xi Chen; Hongwei Liang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Protein Cell       Date:  2012-02-09       Impact factor: 14.870

Review 2.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

3.  First principles of Hamiltonian medicine.

Authors:  Bernard Crespi; Kevin Foster; Francisco Úbeda
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-03-31       Impact factor: 6.237

Review 4.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

5.  Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content.

Authors:  Laura Montermini; Brian Meehan; Delphine Garnier; Wan Jin Lee; Tae Hoon Lee; Abhijit Guha; Khalid Al-Nedawi; Janusz Rak
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

6.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

7.  Stochastic models for horizontal gene transfer: taking a random walk through tree space.

Authors:  Marc A Suchard
Journal:  Genetics       Date:  2005-03-21       Impact factor: 4.562

8.  Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors.

Authors:  Dawei Liu; Xiaoxing Kou; Chider Chen; Shiyu Liu; Yao Liu; Wenjing Yu; Tingting Yu; Ruili Yang; Runci Wang; Yanheng Zhou; Songtao Shi
Journal:  Cell Res       Date:  2018-07-20       Impact factor: 25.617

9.  Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs).

Authors:  Thomas J Bartosh; Mujib Ullah; Suzanne Zeitouni; Joshua Beaver; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-03       Impact factor: 11.205

Review 10.  Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.

Authors:  Johnny C Akers; David Gonda; Ryan Kim; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2013-03-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.